Table 4.
Clinical, pathologic and molecular features of tumors arising in ASH and NASH (Japan cohort).
| ASH | NASH | ||
|---|---|---|---|
| N | 45 | 58 | |
| Age, y mean (SD) | 66.6 (7.7) | 70.2 (9.7) | p = 0.01 |
| M:F ratio | 45:0 | 45:13 | p < 0.001 |
| # tumors mean (SD) | 1.2 (0.7) | 1.3 (1.0) | p = 0.5 |
| Tumor size, cm Mean (SD) | 3.5 (2.1) | 5.2 (3.3) | p = 0.001 |
| Tumor differentiation (per tumor region) | p = 0.67 | ||
| Well | 4 (8.7%) | 6 (9.1%) | |
| Moderate | 38 (83%) | 57 (86%) | |
| Poor | 4 (8.7%) | 3 (4.5%) | |
| Microscopic vascular invasion | 8 (17.8%) | 5 (8.6%) | p = 0.14 |
| Macroscopic vascular invasion | 4 (8.9%) | 0 (0%) | p = 0.03 |
| AFP > 9 | 14 (31%) | 21 (36%) | p = 0.68 |
| Steatohepatitic HCC | 16 (36%) | 15 (26%) | p = 0.39 |
| Molecular subtype (per tumor region) | p = 0.49 | ||
| S1 | 15 (33%) | 15 (23%) | |
| S2 | 6 (13%) | 11 (17%) | |
| S3 | 25 (54%) | 40 (60%) |